miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review

Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.

Article  CAS  PubMed  Google Scholar 

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.

Article  CAS  PubMed  Google Scholar 

Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20.

Article  CAS  PubMed  Google Scholar 

Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.

Article  CAS  PubMed  Google Scholar 

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacFarlane L-A, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill M, Tran N. miRNA interplay: Mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):dmm047662.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci. 2006;103(7):2257–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136(4):586–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Omar HA, El-Serafi AT, Hersi F, Arafa ESA, Zaher DM, Madkour M, et al. Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment. FEBS J. 2019;286(18):3540–57.

Article  CAS  PubMed  Google Scholar 

Pastina P, Nardone V, Croci S, Battaglia G, Vanni F, Bellan C, et al. Anti-cancer activity of dose-fractioned mPE+/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients. J Thorac Dis. 2017;9(9):3123.

Article  PubMed  PubMed Central  Google Scholar 

Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S. Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer. Onco Targets Ther. 2017;10:2665.

Article  PubMed  PubMed Central  Google Scholar 

Fornari F, Ferracin M, Trerè D, Milazzo M, Marinelli S, Galassi M, et al. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, identify cirrhotic patients with HCC. PLoS One. 2015;10(10):e0141448.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J-X, Xu Y, Gao Y, Chen C, Zheng Z-S, Yun M, et al. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway. Mol Cancer. 2017;16(1):1–15.

Article  Google Scholar 

Tang M, Jiang L, Lin Y, Wu X, Wang K, He Q, et al. Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition. Oncotarget. 2017;8(57):97464.

Article  PubMed  PubMed Central  Google Scholar 

Han X, Du C, Chen Y, Zhong X, Wang F, Wang J, et al. Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer. Cancer Biomark. 2019;25(4):325–32.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Liu X, Li Q, Zhang Y. lncRNA LINC00460 promoted colorectal cancer cells metastasis via miR-939-5p sponging. Cancer Manag Res. 2019;11:1779.

Article  PubMed  PubMed Central  Google Scholar 

Shen Y, Chen G, Gao H, Li Y, Zhuang L, Meng Z, et al. miR-939-5p contributes to the migration and invasion of pancreatic cancer by targeting ARHGAP4. Onco Targets Ther. 2020;13:389.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Situ J, Zhang H, Jin Z, Li K, Mao Y, Huang W. MicroRNA-939 directly targets HDGF to inhibit the aggressiveness of prostate cancer via deactivation of the WNT/β-catenin pathway. Onco Targets Ther. 2020;13:4257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen F, Ni X, Chen L, Wang X, Xu J. miR-939-3p promotes epithelial-mesenchymal transition and may be used as a prognostic marker in hepatocellular carcinoma. Oncol Lett. 2020;19(4):2727–32.

CAS  PubMed  PubMed Central  Google Scholar 

Zheng H, Zhao H, Ye G. Overexpression of microRNA-939-5p contributes to cell proliferation and associates poor prognosis in glioma. NeuroMol Med. 2021;23(4):531–9.

Article  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Cancer IAfRo. Pancreas. Global cancer observatory: World Health Organization. 2020. https://gco.iarc.fr/today/explore.

Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28(4–5):645–56.

Article  PubMed  Google Scholar 

Viale PH. The American Cancer Society’s facts & figures: 2020 edition. J Adv Pract Oncol. 2020;11(2):135.

PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

Article  PubMed  Google Scholar 

Shen Y, Xu L, Ning Z, Liu L, Lin J, Chen H, et al. ARHGAP4 regulates the cell migration and invasion of pancreatic cancer by the HDAC2/β-catenin signaling pathway. Carcinogenesis. 2019;40(11):1405–14.

Article  CAS  PubMed  Google Scholar 

Shen Y, Chen G, Zhuang L, Xu L, Lin J, Liu L. ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways. Onco Targets Ther. 2019;12:5003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The lancet. 2016;388(10053):1459–544.

Article  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol. 2020;72(2):250–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hishida M, Nomoto S, Inokawa Y, Hayashi M, Kanda M, Okamura Y, et al. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis. Int J Oncol. 2013;43(1):88–94.

Article  CAS  PubMed  Google Scholar 

Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005;19(4):833–42.

Article  PubMed  Google Scholar 

Egidi MG, Cochetti G, Serva MR, Guelfi G, Zampini D, Mechelli L, et al. Circulating microRNAs and kallikreins before and after radical prostatectomy: are they really prostate cancer markers? BioMed Res Int. 2013;2013:241780.

Article  PubMed  PubMed Central  Google Scholar 

Barry MJ, Simmons LH. Prevention of prostate cancer morbidity and mortality: primary prevention and early detection. Med Clin. 2017;101(4):787–806.

Google Scholar 

Miyake H, Fujisawa M. Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches. Int J Urol. 2013;20(3):301–11.

Article  PubMed  Google Scholar 

Antognelli C, Mezzasoma L, Fettucciari K, Mearini E, Talesa VN. Role of glyoxalase I in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells. Prostate. 2013;73(2):121–32.

Article  CAS  PubMed  Google Scholar 

Antognelli C, Mezzasoma L, Mearini E, Talesa VN. Glyoxalase 1–419

留言 (0)

沒有登入
gif